Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TransDerm Inc.
DescriptionShort interfering RNA (siRNA) that targets the N171K mutant form of the keratin 6A (KRT6A; CK6A) gene
Molecular Target Keratin 6A (KRT6A) (CK6A)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPhase I
Standard Indication Dermatology (unspecified)
Indication DetailsTreat pachyonychia congenita
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today